COVID-19 Records

Reading Room Production — page 368

of 496 pages

← p.367 p.369 → · this page in the original PDF · package

From: "Mclinnes, Pamela (NIH/NIAID)" </O=NIH/OU=NIHEXCHANGE/CN=NIAID/CN=PMCINNES> To: "Fauci, Anthony (NIH/NIAID)" <AFAUCI@niaid.nih.gov> Cc: "Gruber, Robin (NIH/NIAID)" <M @niaid.nih.gov>, "Heilman, Carole (NIH/NIAID)" {EE @ viaic.nit.gov> Subject: More on Buller Date: Thu, 30 Oct 2003 14:37:26 -0500 Importance: Normal Tony: « Mark Buller has an animal model contract from us to evaluate vaccine and antiviral candidates. He mostly utilizes rabbits (rabbit pox) and mice (ectromelia). * He has not made a vaccinia virus IL-4 recombinant and will not do so without our permission. + At Jahrling's request Buller has made a cowpox virus mouse IL-4 recombinant which he transferred to USAMRIID (Jahrling). Buller has no plans to work with it at his own institution. Still awaiting confirmation on source of funding for making the construct. Jahrling has not used the construct in any experiment. It is secured at USAMRIID. * Back to my earlier note, the identity of the US person who expressed concern was Richard Hatchett. Pamela

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/reading_room/368

Records on this page

RecordDateTypePages
More on Buller 2003-10-30 email 368